These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 769200)

  • 21. Transgenic expression of cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin prolongs xenogeneic skin graft survival without extensive immunosuppression in rat burn wounds.
    Wang Y; Wei H; Ni Y; Ge LP; Liu Q; Mao XL; Zhao YJ; Wu J
    J Trauma; 2008 Jul; 65(1):154-62. PubMed ID: 18580521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.
    Chapoval AI; Nelson H; Thibault C
    J Immunol; 1995 Aug; 155(3):1296-303. PubMed ID: 7636196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiolocalization of human pancreatic tumors in athymic mice by monoclonal antibody DU-PAN 1.
    Worlock AJ; Zalutsky MR; Metzgar RS
    Cancer Res; 1990 Nov; 50(22):7246-51. PubMed ID: 2224857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
    Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R; Archibald J; Gress RE
    J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia.
    Cope DA; Dewhirst MW; Friedman HS; Bigner DD; Zalutsky MR
    Cancer Res; 1990 Mar; 50(6):1803-9. PubMed ID: 2407344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Fc binding site for streptococcal protein G is in the C gamma 2-C gamma 3 interface region of IgG and is related to the sites that bind staphylococcal protein A and human rheumatoid factors.
    Stone GC; Sjöbring U; Björck L; Sjöquist J; Barber CV; Nardella FA
    J Immunol; 1989 Jul; 143(2):565-70. PubMed ID: 2738404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of A-cells in affecting the immunostimulating effect of F(ab')2-fragments].
    Bartova LM; Margulis GU; Kulagina NN; Kul'berg AIa
    Biull Eksp Biol Med; 1986 May; 101(5):589-91. PubMed ID: 3708145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human interleukin-10 transduced fetal liver stem cells prolong survival of mouse skin and heart allografts.
    Hase T; Chargui J; Inori F; Yoshimura R; Sembeil R; Nakatani T; Touraine JL
    Transplant Proc; 2005; 37(1):287-8. PubMed ID: 15808621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
    Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged survival of renal allografts in outbred rabbits treated with donor specific F(ab')2 alloantibody.
    Sutherland DE; Howard RJ; Dombrovskis S; Najarian JS
    Ann Surg; 1974 Dec; 180(6):857-63. PubMed ID: 4611361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged survival of corneal allografts incubated in alloantibody fragments.
    Gebhardt BM; Varnell ED; Kaufman HE
    Transplantation; 1999 Feb; 67(4):594-9. PubMed ID: 10071033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Skin allograft, from the donor to the burn patient].
    Gaucher S; Marchix T; Jarraya M
    Soins; 2012; (767):46-8. PubMed ID: 22916399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced allograft survival in H-2 compatible cyclosporine-treated mice.
    Krob MJ; Shelby J
    J Trauma; 1988 Feb; 28(2):225-7. PubMed ID: 3279221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation methods of allografts and their (lack of) influence on clinical results in partial thickness burns.
    Hermans MH
    Burns; 2011 Aug; 37(5):873-81. PubMed ID: 21353745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: is there a clinical difference?
    Hermans MH
    Burns; 2014 May; 40(3):408-15. PubMed ID: 24018214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of the severely burned child with skin transplantation modified by immunosuppressive therapy.
    Diethelm AG; Dimick AR; Shaw JF; Baker HJ; Phillips SJ
    Ann Surg; 1974 Dec; 180(6):814-8. PubMed ID: 4611358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolongation of skin allograft survival by pretreatment of allograft with monoclonal antibody and steroids.
    Levinson R; Gillis M; Goldberg EH; Osler T
    J Burn Care Rehabil; 1988; 9(6):623-8. PubMed ID: 3065339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion-induced sensitization to skin allografts in burned mice.
    Shelby J; Krob MJ
    J Trauma; 1986 Jan; 26(1):54-6. PubMed ID: 3510307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific unresponsiveness to skin allografts in burns.
    Clark GT; Moon DJ; Cunningham PR; Johnson TD; Thomas JM; Thomas FT
    J Surg Res; 1989 May; 46(5):401-4. PubMed ID: 2654477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.